Advantages and clinical applications of natural killer cells in cancer immunotherapy

被引:83
作者
Ames, Erik [1 ]
Murphy, William J. [1 ]
机构
[1] Univ Calif Davis, Sch Med, Dept Dermatol, Sacramento, CA 95817 USA
基金
美国国家卫生研究院;
关键词
NK cells; HSCT; Adoptive transfer; Cytokines; CITIM; 2013; MARROW ALLOGRAFT-REJECTION; CLASS-I MOLECULES; NK CELLS; TUMOR-CELLS; RECOMBINANT INTERLEUKIN-2; PROTEASOME INHIBITION; EFFECTOR-CELLS; LEUKEMIA-CELLS; LINE NK-92; IFN-GAMMA;
D O I
10.1007/s00262-013-1469-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The past decade has witnessed a burgeoning of research and further insight into the biology and clinical applications of natural killer (NK) cells. Once thought to be simple innate cells important only as cytotoxic effector cells, our understanding of NK cells has grown to include memory-like responses, the guidance of adaptive responses, tissue repair, and a delicate paradigm for how NK cells become activated now termed "licensing" or "arming." Although these cells were initially discovered and named for their spontaneous ability to kill tumor cells, manipulating NK cells in therapeutic settings has proved difficult and complex in part due to our emerging understanding of their biology. Therapies involving NK cells may either activate endogenous NK cells or involve transfers of exogenous cells by hematopoietic stem cell transplantation or adoptive cell therapy. Here, we review the basic biology of NK cells, highlighting characteristics which make NK cells particularly useful in cancer therapies. We also explore current treatment strategies that have been used for cancer as well as discuss potential future directions for the field.
引用
收藏
页码:21 / 28
页数:8
相关论文
共 53 条
[31]   Expression of chimeric antigen receptors in natural killer cells with a regulatory-compliant non-viral method [J].
Li, L. ;
Liu, L. N. ;
Feller, S. ;
Allen, C. ;
Shivakumar, R. ;
Fratantoni, J. ;
Wolfraim, L. A. ;
Fujisaki, H. ;
Campana, D. ;
Chopas, N. ;
Dzekunov, S. ;
Peshwa, M. .
CANCER GENE THERAPY, 2010, 17 (03) :147-154
[32]   NKp46 and DNAM-1 NK-cell receptors drive the response to human cytomegalovirus-infected myeloid dendritic cells overcoming viral immune evasion strategies [J].
Magri, Giuliana ;
Muntasell, Aura ;
Romo, Neus ;
Saez-Borderias, Andrea ;
Pende, Daniela ;
Geraghty, Daniel E. ;
Hengel, Hartmut ;
Angulo, Ana ;
Moretta, Alessandro ;
Lopez-Botet, Miguel .
BLOOD, 2011, 117 (03) :848-856
[33]   NK cell-mediated targeting of human cancer and possibilities for new means of immunotherapy [J].
Malmberg, Karl-Johan ;
Bryceson, Yenan T. ;
Carlsten, Mattias ;
Andersson, Sandra ;
Bjorklund, Andreas ;
Bjorkstrom, Niklas K. ;
Baumann, Bettina C. ;
Fauriat, Cyril ;
Alici, Evren ;
Dilber, M. Sirac ;
Ljunggren, Hans-Gustaf .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2008, 57 (10) :1541-1552
[34]   Induced recruitment of NK cells to lymph nodes provides IFN-γ for TH1 priming [J].
Martín-Fontecha, A ;
Thomsen, LL ;
Brett, S ;
Gerard, C ;
Lipp, M ;
Lanzavecchia, A ;
Sallusto, F .
NATURE IMMUNOLOGY, 2004, 5 (12) :1260-1265
[35]  
Meropol NJ, 1996, CLIN CANCER RES, V2, P669
[36]   Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer [J].
Miller, JS ;
Soignier, Y ;
Panoskaltsis-Mortari, A ;
McNearney, SA ;
Yun, GH ;
Fautsch, SK ;
McKenna, D ;
Le, C ;
Defor, TE ;
Burns, LJ ;
Orchard, PJ ;
Blazar, BR ;
Wagner, JE ;
Slungaard, A ;
Weisdorf, DJ ;
Okazaki, IJ ;
McGlave, PB .
BLOOD, 2005, 105 (08) :3051-3057
[37]   NK cells of human secondary lymphoid tissues enhance T cell polarization via IFN-γ secretion [J].
Morandi, Barbara ;
Bougras, Gwenola ;
Muller, William A. ;
Ferlazzo, Guido ;
Munz, Christian .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2006, 36 (09) :2394-2400
[38]   Expression of a CD20-specific chimeric antigen receptor enhances cytotoxic activity of NK cells and overcomes NK-resistance of lymphoma and leukemia cells [J].
Mueller, Tina ;
Uherek, Christoph ;
Maki, Guitta ;
Chow, Kai Uwe ;
Schimpf, Annemarie ;
Klingemann, Hans-Georg ;
Tonn, Torsten ;
Wels, Winfried S. .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2008, 57 (03) :411-423
[39]   Cancer immunoediting by the innate immune system in the absence of adaptive immunity [J].
O'Sullivan, Timothy ;
Saddawi-Konefka, Robert ;
Vermi, William ;
Koebel, Catherine M. ;
Arthur, Cora ;
White, J. Michael ;
Uppaluri, Ravi ;
Andrews, Daniel M. ;
Ngiow, Shin Foong ;
Teng, Michele W. L. ;
Smyth, Mark J. ;
Schreiber, Robert D. ;
Bui, Jack D. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2012, 209 (10) :1869-1882
[40]   Cancer Immunoediting of the NK Group 2D Ligand H60a [J].
O'Sullivan, Timothy ;
Dunn, Gavin P. ;
Lacoursiere, Daphne Y. ;
Schreiber, Robert D. ;
Bui, Jack D. .
JOURNAL OF IMMUNOLOGY, 2011, 187 (07) :3538-3545